AIP1-Mediated Stress Signaling in Atherosclerosis and Arteriosclerosis

Current Atherosclerosis Reports

Volumn 17, Issue 5, 2015, Pages 1-7

  Zhang, Jiqin ^a   Zhou, Huanjiao Jenny ^a,b   Ji, Weidong ^a   Min, Wang ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIP1; Angiogenesis; Arteriosclerosis; Atherosclerosis; ER stress; Inflammation; LPS; Lymphangiogenesis; Oxidative stress; Signaling pathway; TLR (toll like receptor); TNF; Vascular endothelial cell (EC)

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ASK1 INTERACTING PROTEIN 1; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN IRE1; SCAFFOLD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN; CARRIER PROTEIN; MAGI2 PROTEIN, HUMAN;

ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CELLULAR STRESS SIGNAL; DAB2IP GENE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; GENE; GENETIC ASSOCIATION; GRAFT ARTERIOSCLEROSIS; HUMAN; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VASCULAR SMOOTH MUSCLE; VASCULITIS; ANIMAL; GENETICS; METABOLISM; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANIMALS; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CARRIER PROTEINS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84924096640     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-015-0503-z     Document Type: Review

References (46)

1. Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol. 2009;4:71–95.
2. Li HG, Horke S, Forstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237(1):208–19.
3. Robbins GR, Wen H, Ting JP. Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell. 2014;54(2):297–308.
4. Zhou AX, Tabas I. The UPR in atherosclerosis. Semin Immunopathol. 2013;35(3):321–32.
5. Liu Y, Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Cir Res. 2002;90(6):1259–66.
6. Liu Y, Yin G, Surapisitchat J, Berk BC, Min W. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest. 2001;107(721181880):917–23.
7. Zhang R, He X, Liu W, Lu M, Hsieh JT, Min W. AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest. 2003;111(12):1933–43.
8. Zhang H, Zhang R, Luo Y, D’Alessio A, Pober JS, Min W. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. J Biol Chem. 2004;279(43):44955–65.
9. Zhang H, Zhang H, Lin Y, Li J, Pober JS, Min W. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation. J Biol Chem. 2007;282(20):14788–96.
10. Zhang H, He Y, Dai S, Xu Z, Luo Y, Wan T, et al. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J Clin Invest. 2008;118(12):3904–16.
11. Wan T, Liu T, Zhang H, Tang S, Min W. AIP1 functions as Arf6-GAP to negatively regulate TLR4 signaling. J Biol Chem. 2010;285(6):3750–7.
12. Yu L, Qin L, Zhang H, He Y, Chen H, Pober J, et al. AIP1 prevents graft arteriosclerosis by inhibiting IFN-γ-dependent smooth muscle cell proliferation and intimal expansion. Cir Res. 2011;109(4):418–27.
13. Zhou HJ, Chen X, Huang Q, Liu R, Zhang H, Wang Y, et al. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses. Arterioscler Thromb Vasc Biol. 2014;34(3):603–15.
14. Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP, et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet. 2010;42(8):692–7.
15. Chen H, Pong RC, Wang Z, Hsieh JT. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Genomics. 2002;79(4):573–81.
16. Chen H, Toyooka S, Gazdar AF, Hsieh JT. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem. 2003;278(5):3121–30.
17. Chen H, Tu SW, Hsieh JT. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem. 2005;280(23):22437–44.
18. Wang Z, Tseng CP, Pong RC, Chen H, McConnell JD, Navone N, et al. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. J Biol Chem. 2002;277(15):12622–31.
19. Wajant H. Increasing complexity in TNFR1 signaling. Febs J. 2011;278(6):861.
20. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65.
21. Wajant H, Scheurich P. TNFR1-induced activation of the classical NF-kappaB pathway. Febs J. 2011;278(6):862–76.
22. Pober JS, Min W. Endothelial cell dysfunction, injury and death. Handb Exp Pharmacol. 2006;176(Pt 2):135–56.
23. Min W, Lin Y, Tang S, Yu L, Zhang H, Wan T, et al. AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circ Res. 2008;102(7):840–8.
24. Li X, Zhang R, Luo D, Park SJ, Wang Q, Kim Y, et al. Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation. J Biol Chem. 2005;280(15):15061–70.
25. Li X, Luo Y, Yu L, Lin Y, Luo D, Zhang H, He Y, Kim YO, Kim Y, Tang S, et al. SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis. Cell Death Differ. 2008.
26. Carpentier I, Coornaert B, Beyaert R. Function and regulation of tumor necrosis factor type 2. Curr Med Chem. 2004;11(16):2205–12.
27. Ji W, Li Y, Wan T, Wang J, Zhang H, Chen H, et al. Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling. Arterioscler Thromb Vasc Biol. 2012;32(9):2271–9.
28. Luo D, He Y, Zhang H, Yu L, Chen H, Xu Z, Tang S, Urano F, and Min W. AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response. J Biol Chem. 2008.
29. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511.
30. Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 2002;420(6913):329–33.
31. Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol. 2001;2(9):835–41.
32. Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell. 2006;125(5):943–55.
33. Funakoshi Y, Hasegawa H, Kanaho Y. Regulation of PIP5K activity by Arf6 and its physiological significance. J Cell Physiol. 2011;226(4):888–95.
34. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307.
35. Huang Q, Qin L, Dai S, Zhang H, Pasula S, Zhou H, et al. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2013;33(4):795–804. The first study on the role of AIP1 in atherosclerosis.
36. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol. 2005;25(6):1213–9.
37. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386(6620):73–7.
38. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Pastorino AM, et al. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens. 1998;16(12 Pt 299101992):1913–9.
39. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275(17):12633–8.
40. Tellides G, Pober JS. Interferon-gamma axis in graft arteriosclerosis. Circ Res. 2007;100(5):622–32.
41. Pober JS, and Sessa WC. Inflammation and the blood microvascular system. Cold Spring Harb Perspect Biol. 2014;7 (1). Excellent review on inflammation.
42. Pober JS, Jane-wit D, Qin L, Tellides G. Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. Arterioscler Thromb Vasc Biol. 2014;34(8):1609–14. Good summary on graft arteriosclerosis.
43. Min W, Pober JS. AIP1 in graft arteriosclerosis. Trends Cardiovasc Med. 2011;21(8):229–33.
44. Qin L, Yu L, and Min W. Mouse models for graft arteriosclerosis. Journal of visualized experiments. JoVE. 201375. The video covers the detailed procedure on graft transplanation.
45. Qin L, Zhang H, Liu R, Tellides G, Min W, and Yu L. SOCS1 prevents graft arteriosclerosis by preserving endothelial cell function. J Am Coll Cardiol. 2014;63(1):21–9. This paper won Parmley Award, the best research article in JACC 2013 and show similar function of SOCS1 with AIP1 in limiting inflammation and atherosclerosis.
46. Harrison SC, Cooper JA, Li K, Talmud PJ, Sofat R, Stephens JW, et al. Association of a sequence variant in DAB2IP with coronary heart disease. Eur Heart J. 2012;33(7):881–8.